Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.640
+0.120 (2.65%)
Nov 21, 2024, 1:55 PM EST - Market open
Sagimet Biosciences Employees
As of December 31, 2023, Sagimet Biosciences had 10 total employees, including 8 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,751,700
Market Cap
148.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10 | 0 | - |
Dec 31, 2022 | 10 | 3 | 42.86% |
Dec 31, 2020 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Pro-Dex | 148 |
Seer, Inc. | 147 |
Adverum Biotechnologies | 121 |
Vaxart | 109 |
Myomo | 106 |
Black Diamond Therapeutics | 54 |
Sensus Healthcare | 35 |
Achieve Life Sciences | 22 |
SGMT News
- 6 days ago - Sagimet: More Than Just A MASH Drug Development Biotech - Seeking Alpha
- 9 days ago - Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne - PRNewsWire
- 4 weeks ago - Sagimet Soars: FDA Breakthrough Therapy Designation And Lancet Review Validate Denifanstat - Seeking Alpha
- 5 weeks ago - Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology - GlobeNewsWire
- 7 weeks ago - Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH - GlobeNewsWire
- 7 weeks ago - Sagimet Biosciences to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference and Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit - GlobeNewsWire
- 4 months ago - Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors - GlobeNewsWire